NOTE: Before submitting your application, please verify at https://rii.usc.edu/funding/ that you have downloaded the latest version of the Request for Proposals.
The Ming Hsieh Institute for Research on Engineering-Medicine for Cancer (MHI) sponsors the Ming Hsieh Institute Research Award aims to make USC an international leader in translational research that bridges basic science, engineering, computing, and medicine. The MHI was established in 2010 through a generous gift from Ming Hsieh, a graduate of the USC Viterbi School of Engineering, founder of Cogent Systems and Fulgent Genetics, USC Trustee, and a member of the National Academy of Engineering and the National Academy of Inventors. The Institute's main goal is to support integrated interdisciplinary translational research that speeds discovery and creates pathways to rapidly improve the lives of cancer patients. Its commitment to supporting new and creative approaches and breakthrough interdisciplinary ideas drives advances in engineering, computing, and science into treatments and cures for cancer. The Ming Hsieh Institute Research Award aims to promote the integration of engineering, scientific and medical research that together generates novel thinking and the interdisciplinary and collaborative research needed to speed discovery and be translated into real improvements in human health.
For additional information, and to download the Request for Proposals, please click here.
If you are experiencing technical issues submitting your proposal or have additional question, please contact the Research Initiatives&Infrastructure at rii@usc.edu.
This portal requires information about the PIs and Co-PIs in addition to department and contact information, including the 10-digit USC ID#. Please have this material prepared before beginning this application.
RII - Ming Hsieh Institute Research Award
NOTE: Before submitting your application, please verify at https://rii.usc.edu/funding/ that you have downloaded the latest version of the Request for Proposals.
The Ming Hsieh Institute for Research on Engineering-Medicine for Cancer (MHI) sponsors the Ming Hsieh Institute Research Award aims to make USC an international leader in translational research that bridges basic science, engineering, computing, and medicine. The MHI was established in 2010 through a generous gift from Ming Hsieh, a graduate of the USC Viterbi School of Engineering, founder of Cogent Systems and Fulgent Genetics, USC Trustee, and a member of the National Academy of Engineering and the National Academy of Inventors. The Institute's main goal is to support integrated interdisciplinary translational research that speeds discovery and creates pathways to rapidly improve the lives of cancer patients. Its commitment to supporting new and creative approaches and breakthrough interdisciplinary ideas drives advances in engineering, computing, and science into treatments and cures for cancer. The Ming Hsieh Institute Research Award aims to promote the integration of engineering, scientific and medical research that together generates novel thinking and the interdisciplinary and collaborative research needed to speed discovery and be translated into real improvements in human health.
For additional information, and to download the Request for Proposals, please click here.
If you are experiencing technical issues submitting your proposal or have additional question, please contact the Research Initiatives&Infrastructure at rii@usc.edu.
This portal requires information about the PIs and Co-PIs in addition to department and contact information, including the 10-digit USC ID#. Please have this material prepared before beginning this application.